BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21256581)

  • 1. Surgical staging of early stage epithelial ovarian cancer: results from the CDC-NPCR ovarian patterns of care study.
    Cress RD; Bauer K; O'Malley CD; Kahn AR; Schymura MJ; Wike JM; Stewart SL; Leiserowitz GS
    Gynecol Oncol; 2011 Apr; 121(1):94-9. PubMed ID: 21256581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
    Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
    Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.
    Rungruang BJ; Miller A; Krivak TC; Horowitz NS; Rodriguez N; Hamilton CA; Backes FJ; Carson LF; Friedlander M; Mutch DG; Goodheart MJ; Tewari KS; Wenham RM; Bookman MA; Maxwell GL; Richard SD
    Cancer; 2017 May; 123(6):985-993. PubMed ID: 27864921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of guideline adherence on patient outcomes in early-stage epithelial ovarian cancer.
    Lee JY; Kim TH; Suh DH; Kim JW; Kim HS; Chung HH; Park NH; Song YS; Kang SB
    Eur J Surg Oncol; 2015 Apr; 41(4):585-91. PubMed ID: 25624160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphadenectomy in surgical stage I epithelial ovarian cancer.
    Svolgaard O; Lidegaard O; Nielsen ML; Nedergaard L; Mosgaard BJ; Lidang M; Mogensen O; Kock K; Blaakaer J; Staehr E; Andersen ES; Grove A; Høgdall C
    Acta Obstet Gynecol Scand; 2014 Mar; 93(3):256-60. PubMed ID: 24447203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic Versus Laparotomic Surgical Staging for Early-Stage Ovarian Cancer: A Case-Control Study.
    Gallotta V; Petrillo M; Conte C; Vizzielli G; Fagotti A; Ferrandina G; Fanfani F; Costantini B; Carbone V; Scambia G
    J Minim Invasive Gynecol; 2016; 23(5):769-74. PubMed ID: 26995493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study.
    O'Malley CD; Shema SJ; Cress RD; Bauer K; Kahn AR; Schymura MJ; Wike JM; Stewart SL
    J Womens Health (Larchmt); 2012 Sep; 21(9):887-94. PubMed ID: 22816528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands.
    Timmermans M; Sonke GS; Van de Vijver KK; van der Aa MA; Kruitwagen RFPM
    Eur J Cancer; 2018 Jan; 88():31-37. PubMed ID: 29179135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of lymph node dissection and adjuvant chemotherapy on survival: A nationwide cohort study of patients with clinical early-stage ovarian cancer.
    Kleppe M; van der Aa MA; Van Gorp T; Slangen BF; Kruitwagen RF
    Eur J Cancer; 2016 Oct; 66():83-90. PubMed ID: 27536891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pelvic retroperitoneal invasion and distant nodal metastases in epithelial ovarian cancer.
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Pérez-Milán F; Ortiz-Quintana L
    Surg Oncol; 2014 Mar; 23(1):40-4. PubMed ID: 24183480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic.
    Wahner Hendrickson AE; Hawthorne KM; Goode EL; Kalli KR; Goergen KM; Bakkum-Gamez JN; Cliby WA; Keeney GL; Visscher DW; Tarabishy Y; Oberg AL; Hartmann LC; Maurer MJ
    Gynecol Oncol; 2015 Apr; 137(1):77-85. PubMed ID: 25620544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
    Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
    Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional variation in surgical assessment of lymph nodes for staging among women with early-stage epithelial ovarian cancer.
    Ulanday KT; Ward KK; Macera CA; Ji M; Plaxe SC
    Gynecol Oncol; 2014 Feb; 132(2):411-5. PubMed ID: 24246773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of surgical staging in patients with apparent early stage epithelial ovarian carcinoma.
    Hengeveld EM; Zusterzeel PLM; Lajer H; Høgdall CK; Rosendahl M
    Gynecol Oncol; 2019 Aug; 154(2):308-313. PubMed ID: 31230820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?
    Sahin H; Meydanli MM; Sari ME; Yalcin I; Çoban G; Ozkan NT; Cuylan ZF; Erdem B; Gungorduk K; Akbayir Ö; Dede M; Salman MC; Güngör T; Ayhan A
    J Ovarian Res; 2018 Mar; 11(1):21. PubMed ID: 29506569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The omentum and omentectomy in epithelial ovarian cancer: a reappraisal: part II--The role of omentectomy in the staging and treatment of apparent early stage epithelial ovarian cancer.
    Arie AB; McNally L; Kapp DS; Teng NN
    Gynecol Oncol; 2013 Dec; 131(3):784-90. PubMed ID: 24056005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: a Gynecologic Oncology Group study.
    Rungruang B; Miller A; Richard SD; Hamilton CA; Rodriguez N; Bookman MA; Maxwell GL; Krivak TC; Horowitz NS
    Gynecol Oncol; 2012 Jan; 124(1):53-8. PubMed ID: 22032836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-surgical management of ovarian cancer: Prevalence and implications.
    Shalowitz DI; Epstein AJ; Ko EM; Giuntoli RL
    Gynecol Oncol; 2016 Jul; 142(1):30-37. PubMed ID: 27107721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer--a population-based study.
    Jordan S; Steer C; DeFazio A; Quinn M; Obermair A; Friedlander M; Francis J; O'Brien S; Goss G; Wyld D; Australian Ovarian Cancer Study Group ; Webb P;
    Gynecol Oncol; 2013 May; 129(2):310-7. PubMed ID: 23403164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of systematic lymph node dissection in advanced epithelial ovarian cancer during interval debulking surgery performed after neoadjuvant chemotherapy.
    Eoh KJ; Yoon JW; Lee I; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
    J Surg Oncol; 2017 Sep; 116(3):329-336. PubMed ID: 28542980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.